Nihal AlMuraikhi

11PUBLICATIONS
18CO-AUTHORS
BiomaterialsMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 15, 2026
Immune-Inflammatory Hub Genes Intersecting with a Ferroptosis-Associated Gene Set in Active Tuberculosis: A Multi-Dataset Bioinformatics Study.

|Mar 28, 2026
Dual Inhibition of GSK3 and JAK by BIO Suppresses Osteoblast Differentiation and Mineralization of Human Mesenchymal Cells.

Nihal Almuraikhi, Latifa Alkhamees, Sumaiya Tareen

|Mar 28, 2026
Multi-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma.

Rasha Elsayim, Heba W Alhamdi, Nihal Almuraikhi

|Feb 04, 2026
Evaluation of metformin's effect on 5-fluorouracil-induced cardiotoxicity through cellular protection.

Nahlah Fahad Alreshidi, Reham Abdullah Al-Dhelaan, Amjad Yousuf

|Jul 23, 2025
Dose-Dependent Effects of TGF-β Inhibition on Osteoblast Differentiation and Wound Healing.

Nihal Almuraikhi, Latifa Alkhamees, Sumaiya Tareen

|May 26, 2023
Inhibition of TGF-β type I receptor by SB505124 down-regulates osteoblast differentiation and mineralization of human mesenchymal stem cells.

Nihal Almuraikhi

Pageof 2

Frequent Collaborators

5 joint publications

Manikandan Muthurangan

2 joint publications

Esra'a Abudouleh

1 joint publications

Norah A AlHowaish

1 joint publications

Amer Mahmood